Phase 1 and phase 2 results highlight promise of ADCs for hard-to-treat cancers
Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. […]
A team at Massachusetts General Hospital uncovered that an immune defense protein, Resistin-like molecule gamma, attacks heart cells […]
Discontent between the GP profession and the government is becoming more evident as sparks fly over how reforms […]
The US CDC’s Advisory Committee on Immunization Practices (ACIP) has announced plans for a new working group to […]
The Medicines and Healthcare Products Regulatory Agency (MHRA) has just approved gepotidacin (Blujepa), the UK’s first new type […]
Putting job advisers in more general practices to help sick and disabled people back into work risks discouraging […]
Linzagolix with add-back Therapy accepted for use within NHS Scotland
Blenrep combination offers improved survival for those ineligible for lenalidomide